CBL-514 in India: What It Is, Research Background & Wholesale Sourcing (2026)

CBL-514 is an investigational small-molecule compound developed by Caliway Biopharmaceuticals and studied for non-surgical, localized fat reduction. It has been getting a lot of attention from research buyers in India. This guide explains what it is, how it differs from peptides, and how to source it for research.

What Is CBL-514?

CBL-514 is not a peptide. It is a small molecule that, in published preclinical and early clinical research, is described as triggering lipolysis (the breakdown of stored fat) in subcutaneous adipocytes when delivered to a targeted fat area. It remains an investigational compound and is not approved as a medicine in India or elsewhere.

CBL-514 vs GLP-1 Peptides

• Mechanism: GLP-1 class compounds such as Ret3trutide and Tirzepatide act systemically on appetite and metabolism. CBL-514 is studied as a localized agent acting on fat tissue directly.
• Research focus: systemic weight management (GLP-1 class) versus body-contouring and localized adipose research (CBL-514).
• Molecule type: peptide versus small molecule.

Available Sizes: 10mg and 20mg

PeptideBazaar supplies CBL-514 in 10mg and 20mg research vials, HPLC verified, with a batch certificate of analysis (COA) on request. This compound is available for wholesale research orders only.

Warehouses: India, US and UK

Stock is held across warehouses in India, the US and the UK. Because availability can differ by warehouse, we confirm the latest stock update for each location on WhatsApp before you order.

How to Order

Message us on WhatsApp from the CBL-514 page with your target vial count. We reply with bulk rates, minimum order quantity and dispatch timelines. Payment by UPI or COD with a 30% advance.

All products are sold strictly for in-vitro laboratory research and analytical use only. Not for human or animal consumption.